Sarasota Memorial Joins International Study to Prevent Atrial Fibrillation After Heart Surgery
Business
SRQ DAILY MONDAY BUSINESS EDITION
MONDAY APR 20, 2026 |
Up to half of heart surgery patients develop atrial fibrillation (AFib) following heart surgery, a common complication that increases their risk of stroke, heart failure and quality of life. Sarasota Memorial is working to address that challenge, joining 75 research sites in the U.S. and abroad testing a proactive surgical approach designed to prevent AFib from impacting patients after surgery. The local study is led by Jeffrey Sell, MD, cardiothoracic surgeon with SMH’s First Physicians Group, with the research team at SMH’s Kolschowsky Research and Education Institute.
« View The Monday Apr 20, 2026 SRQ Daily Edition
« Back To SRQ Daily Archive
